Quantitative Models in Life Science Business - Original PDF
نویسندگان: Jung Kyu Canci · Philipp Mekler · Gang Mu
خلاصه: The pharmaceutical industry is a key, yet complex sector within the global econ- omy. Organizationally, its complexity is outlined by an involved business model, an intricate organizational structure, and a challenging environment. Economically, the pharmaceutical industry has been characterized by high profit margins; this mainly as a result of substantial research and development (R&D) investment and its legal protection by patents. Over time the original situation has evolved further, gener- ating two major types of pharmaceutical firms: originators and generic producers. High R&D investment is a characteristic of the originator pharmaceutical companies which produce patent-protected drugs, as well as biotech specialists which produce biologics. The generic producers, on the other hand, do not incur the initial R&D expenses (or less so) and in general produce drugs lacking patent protection. On top of this now traditional set, new segments have arisen in the pharmaceutical indus- try, comprising services in or around the traditional drug industry, e.g. diagnostic or data-oriented endeavours.